Clinical Research and Studies Testing
ARUP participates in clinical research
and clinical-study testing that may result in improvements in medical care. Participation provides opportunities for
ARUP to evaluate new technologies and methodologies, as well as to establish relationships, collaborations, and academic
The clinical research and studies department provides a framework for evaluating the strategic value of clinical
research studies to ARUP and assesses the potential benefit(s) and impact(s) to R&D activities and to ARUPís operational effectiveness. A preliminary evaluation may include legal, regulatory, pricing, specimen type, test mix, and specimen
To ensure a high probability of success, each project is considered on a case-by-case basis. Studies are evaluated for strategic fit to the mission of ARUP, regulatory requirements, and testing capabilities, as well as the objectives and initiatives of our medical directors. Each study request is carefully evaluated for added value for improving the field of medicine, laboratory testing, and the academic mission of ARUP. Requests are diverse and often subject to strict regulatory requirements. ARUP generally does not pursue contract
work that supports clinical trials for FDA submissions.
ARUP supports select clinical studies in which testing falls under CLIA/CAP regulations and can be facilitated within ARUPís existing workflow, operations, regulatory capacity, and processes for standard reference laboratory work.
Prior to the submission of study specimens and, preferably, prior to collection, contact ARUPís Clinical Research & Studies Department at (801) 583-2787 or (800) 242-2787.
- Jon Lowe, CRS Specialist II, ext. 2021, or via email
- Pilar Jimenez, CRS Specialist I, ext. 3289, or via email
For requests from the University of Utah, please contact:
Kathy Carlson, VP, UHSC Services, at (801) 581-2493, or via email.